Education
About Us
Working with TipRanks
Follow Us
Wendy B. Young Insider Profile
4 Followers
Wendy B. Young, Director at Rapport Therapeutics, Inc., holds 9.50K shares in Rapport Therapeutics, Inc. (Ticker: RAPP). Most recently, Wendy B. Young Bought 3,500 shares of Rapport Therapeutics, Inc. on Sep 11, 2025 for an estimated value of $79.10K.
Wendy B. Young Rapport Therapeutics, Inc. (RAPP)Director
Rapport Therapeutics, Inc. (RAPP)
Director
Ranked #23,999 out of 106,131 Corporate Insiders
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+107.40%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Wendy B. Young holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Mar 13, 2025 - Today
Return:+189.70%
The most profitable trade made by Wendy B. Young
Wendy B. Young's Trading History
List of latest transactions for each holding click on a transaction to see Wendy B. Young's performance on stock
You May Also Like
Wendy B. Young insider profile FAQ
What is the percentage of profitable transactions made by Wendy B. Young?
The percentage of profitable transactions made by Wendy B. Young is 100%.
What is the average return per transaction made by Wendy B. Young?
The average return per transaction made by Wendy B. Young is 107.40%.
What stocks does Wendy B. Young hold?
Wendy B. Young holds: RAPP stocks.
What was Wendy B. Young’s latest transaction?
Wendy B. Young latest transaction was an Informative Buy of $79.10K.
What was Wendy B. Young's most profitable transaction?
Wendy B. Young’s most profitable transaction was an Informative Buy of RAPP stock on March 13, 2025. The return on the trade was 189.70%.
What is Wendy B. Young's role in Rapport Therapeutics, Inc.?
Wendy B. Young's role in Rapport Therapeutics, Inc. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.